Journal of clinical oncology (JCO) |
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
The Lancet |
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a ra |
mai. 19 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. |
mai. 19 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. |
mai. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. |
mar. 19 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study. |
mar. 19 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial. |
mar. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study. |
fév. 19 |
3 ♥ |
Carcinome hépatocellulaire (CHC) |
Journal of clinical oncology (JCO) |
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled Study-XELAVIRI (AIO KRK0110). |
Jan. 19 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2. |
Jan. 19 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer. |
oct. 18 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer. |
oct. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Associations of Pre- and Postdiagnosis Diet Quality With Risk of Mortality Among Men and Women With Colorectal Cancer |
oct. 18 |
4 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Efficacy and Tolerability of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The Open-Label, Randomized, Phase III TAILOR Trial. |
sep. 18 |
3 ♥ |
Cancer colorectal (CCR) |
Journal of clinical oncology (JCO) |
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. |
sep. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial. |
juil. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Crohn's and Colitis |
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial. |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of Crohn's and Colitis |
Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update. |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Journal of clinical oncology (JCO) |
Popstantot |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
The Lancet |
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. |
mai. 18 |
5 ♥ |
Cancers autres (hors CCR et CHC) |
Gut |
Acute lower GI bleeding in the UK: patient characteristics, interventions and outcomes in the first nationwide audit. |
avr. 18 |
3 ♥ |
Endoscopie/Imagerie |
Journal of Crohn's and Colitis |
Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases. |
avr. 18 |
3 ♥ |
MICI |
Journal of Crohn's and Colitis |
Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women. |
avr. 18 |
3 ♥ |
MICI |
The Lancet |
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. |
avr. 18 |
5 ♥ |
Carcinome hépatocellulaire (CHC) |